Evidence map›Paper›PMID 28085492›Full record

ArticleAmerican journal of respiratory and critical care medicine2017

Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to Aeroallergens.

Jaideep Dhariwal, Aoife Cameron, Maria-Belen Trujillo-Torralbo, Ajerico Del Rosario, Eteri Bakhsoliani, Malte Paulsen, David J Jackson, Michael R Edwards, Batika M J Rana, David J Cousins and 4 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03644680 (Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study), which is not on this map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03644680 nacompletednot on this mapstarted 2018, after this paper: background citation

Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study

TypeinterventionalSponsorMedical University of ViennaRan2018 to 2019Enrolled36ConditionsAllergic Rhinitis, Allergic InflammationArmsNasal Provocation with Birch Extract, Nasal Provocation with NaCl 0.9%
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 83 citations in OpenAlex.

  1. Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma ExacerbationsAmerican journal of respiratory and critical care medicine · 2021
    Trial
  2. Group 2 innate lymphoid cells: Where are we 15 years out?The Journal of allergy and clinical immunology · 2026
    Review
  3. Review
  4. Review
  5. Characterizing the symptomatology and pathophysiology of allergic rhinitis using a nasal allergen challenge model - a subset of the allergic rhinitis microbiome study.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025
    Article
  6. Article
  7. Recent Studies and Prospects of Biologics in Allergic Rhinitis Treatment.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Unveiling the Neuron-mediated Group 2 Innate Lymphoid Cell Activation in Human Asthma.American journal of respiratory and critical care medicine · 2024
    Article
  10. Review
  11. Group 2 Innate Lymphoid Cells in Allergic Rhinitis.Journal of inflammation research · 2024
    Review
  12. Article
  13. Review
  14. Ischemia reperfusion injury facilitates lung allograft acceptance through IL-33-mediated activation of donor-derived IL-5 producing group 2 innate lymphoid cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Jaideep Dhariwal1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Aoife Cameron1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Maria-Belen Trujillo-Torralbo1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Ajerico Del Rosario1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Eteri Bakhsoliani1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Malte Paulsen3 St. Mary's Flow Cytometry Core Facility, London, United Kingdom.
David J Jackson1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Michael R Edwards1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Batika M J Rana5 Department of Respiratory Medicine & Allergy, King's College London, London, United Kingdom; and.
David J Cousins2 Medical Research Council Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom.
Trevor T Hansel1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Sebastian L Johnston1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
Ross P Walton1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom.
MRC-GSK Strategic Alliance Consortium
Lung Institute · USKing's College London · GBNational Health Service · GBSt Mary's University Twickenham London · GBUniversity of Leicester · GB

Funding

Medical Research Council G1000758Medical Research Council G1100238
6 · The paper itself

Abstract

rationaleNewly characterized type 2 innate lymphoid cells (ILC2s) display potent type 2 effector functionality; however, their contribution to allergic airways inflammation and asthma is poorly understood. Mucosal biopsy used to characterize the airway mucosa is invasive, poorly tolerated, and does not allow for sequential sampling.

objectivesTo assess the role of ILC2s during nasal allergen challenge in subjects with allergic rhinitis using novel noninvasive methodology.

methodsWe used a human experimental allergen challenge model, with flow cytometric analysis of nasal curettage samples, to assess the recruitment of ILC2s and granulocytes to the upper airways of subjects with atopy and healthy subjects after allergen provocation. Soluble mediators in the nasal lining fluid were measured using nasosorption. MEASUREMENTS AND MAIN

resultsAfter an allergen challenge, subjects with atopy displayed rapid induction of upper airway symptoms, an enrichment of ILC2s, eosinophils, and neutrophils, along with increased production of IL-5, prostaglandin D2, and eosinophil and T-helper type 2 cell chemokines compared with healthy subjects. The most pronounced ILC2 recruitment was observed in subjects with elevated serum IgE and airway eosinophilia.

conclusionsThe rapid recruitment of ILC2s to the upper airways of allergic patients with rhinitis, and their association with key type 2 mediators, highlights their likely important role in the early allergic response to aeroallergens in the airways. The novel methodology described herein enables the analysis of rare cell populations from noninvasive serial tissue sampling.

Indexed as

AdolescentAdultAllergensFemaleFlow CytometryHumansImmunity, InnateLymphocytesMaleMiddle AgedNasal MucosaRhinitis, AllergicTh2 CellsYoung AdultAllergensallergic airway inflammationasthmaILC2Th2

Identifiers

PMID28085492
PMCPMC5476911
OpenAlexW2587506218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.